Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration

Journal of Cell Biology

Volumn 178, Issue 1, 2007, Pages 155-165

  Makagiansar, Irwan T ^a,b   Williams, Scott ^a,c   Mustelin, Tomas ^a,d   Stallcup, William B ^a  

^a BURNHAM INSTITUTE   (United States)

^b EMD Biosciences Inc   (United States)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ALPHA; PROTEOGLYCAN; THREONINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LAMELLAR BODY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL PROCESSING;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; ANTIGENS, CD29; ASTROCYTOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; GENETIC VECTORS; HUMANS; HYBRIDOMAS; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; PSEUDOPODIA; RATS; RECOMBINANT FUSION PROTEINS; THREONINE;

EID: 34347388427     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200612084     Document Type: Article

References (55)

1. Alonso, A., J. Sasin, N. Bottini, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell. 117:699-711.
2. Barritt, D., M. Pearn, A. Zisch, S. Lee, R. Javier, E. Pasquale, and W.B. Stallcup. 2000. The multi-PDZ protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2. J. Cell. Biochem. 79:213-224.
3. Borges, E., Y. Jan, and E. Ruoslahti. 2000. Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor-2 bind to the β3 integrin through its extracellular domain. J. Biol. Chem. 275:39867-39873.
4. Burg, M.A., E. Tillet, R. Timpl, and W.B. Stallcup. 1996. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J. Biol. Chem. 271:26110-26116.
5. Burg, M.A., A. Nishiyama, and W.B. Stallcup. 1997. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp. Cell Res. 235:254-264.
6. Chekenya, M., M. Hjelstuen, P. Enger, F. Thorsen, A. Jacob, B. Probst, O. Haraldseth, G. Pilkington, A. Butt, J.M. Levine, and R. Bjerkvig. 2002. NG2 proteoglycan promotes angiogenesis-dependent tumor growth in the central nervous system by sequestering angiostatin. FASEB J. 16:586-598.
7. Chen, C., W. Wang, J. Kuo, H. Tsai, J. Lin, Z. Chang, and R. Chen. 2005. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 24:294-304.
8. Cooper, J., B. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 99:387-402.
9. Cox, B.D., M. Natarajan, M.R. Stettner, and C.L. Gladson. 2006. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell. Biochem. 99:35-52.
10. Defillippi, P., P. Di Stefano, and S. Cabodi. 2006. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol. 16:257-263.
11. Delmas, C., N. Aragou, S. Poussard, P. Cottin, J. Darbon, and S. Manenti. 2003. MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J. Biol. Chem. 278:12443-12451.
12. Doane, K.J., S.J. Howell, and D.E. Birk. 1998. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta-1 integrin and NG2, during avian corneal stromal development. Invest. Opththalmol. Vis. Sci. 39:263-275.
13. Eisenmann, K., J.B. McCarthy, M. Simpson, P. Keely, J.-L. Guan, K. Tachibana, L. Lim, E. Manser, L. Furcht, and J. Iida. 1999. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through cdc42, Ack-1, and p130cas. Nat. Cell Biol. 1:507-513.
14. Fang, X., M.A. Burg, D. Barritt, K. Dahlin-Huppe, A. Nishiyama, and W.B. Stallcup. 1999. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol. Biol. Cell. 10:3373-3387.
15. Fantz, D., D. Jacobs, D. Glossip, and K. Kornfeld. 2001. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276:27256-27265.
16. Farin, A., S. Suzuki, M. Weiker, J. Goldman, J. Bruce, and P. Canoll. 2006. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia. 53:799-808.
17. Fukushi, J., I.T. Makagiansar, and W.B. Stallcup. 2004. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin. Mol. Biol. Cell. 15:3580-3590.
18. Giese, A., R. Bjerkvig, M. Berens, and M. Westphal. 2003. Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 21:1624-1636.
19. Ginnan, R., and H. Singer. 2005. PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 288:C1193-C1201.
20. Goretzki, L., M.A. Burg, K.A. Grako, and W.B. Stallcup. 1999. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 274:16831-16837.
21. Goretzki, L., C. Lombardo, and W.B. Stallcup. 2000. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen). J. Biol. Chem. 275:28625-28633.
22. Grako, K.A., T. Ochiya, D. Barritt, A. Nishiyama, and W.B. Stallcup. 1999. PDGF alpha-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J. Cell Sci. 112:905-915.
23. Iida, J., A. Meijne, R. Spiro, E. Roos, L. Furscht, and J.B. McCarthy. 1995. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and α4β1 integrin. Cancer Res. 55:2177-2185.
24. Lokker, N., C. Sullivan, S. Hollenbach, M. Israel, and N. Giese. 2002. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62:3729-3735.
25. Luque, A., M. Gomez, W. Puzon, Y. Takada, F. Sanchez-Madrid, and C. Cabanas. 1996. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta-1 chain. J. Biol. Chem. 271:11067-11075.
26. Majumdar, M., K. Vuori, and W.B. Stallcup. 2003. Engagement of the NG2 proteoglycan triggers cell spreading via rac and p130cas. Cell. Signal. 15:79-84.
27. Makagiansar, I.T., S. Williams, K. Dahlin-Huppe, J. Fukushi, T. Mustelin, and W.B. Stallcup. 2004. Phosphorylation of NG2 proteoglycan by protein kinase C-α regulates polarized membrane distribution and cell motility. J. Biol. Chem. 279:55262-55270.
28. Manning, B.D., and L.C. Cantley. 2002. Hitting the target: emerging technologies in the search for kinase substrates. Sci. STKE. doi:10.1126/ stke.2002.162.pe49.
29. Manning, G., D. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002. The protein kinase complement of the human genome. Science. 298:1912-1934.
30. Midwood, K., and D. Salter. 2001. NG2/HMPG modulation of human articular chondrocyte adhesion to type VI collagen is lost in osteoarthritis. J. Pathol. 195:631-635.
31. Nishiyama, A., K. Dahlin, J. Prince, S. Johnstone, and W.B. Stallcup. 1991. The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol. 114:359-371.
32. Nishiyama, A., X. Lin, N. Giese, C. Heldin, and W.B. Stallcup. 1996. Interaction between NG2 proteoglycan and PDGFα-receptor on O2A cells is required for optimal response to PDGF. J. Neurosci. Res. 43:315-330.
33. Ozerdem, U., and W.B. Stallcup. 2004. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis. 7:269-276.
34. Paul, S., G. Snyder, H. Yokakura, M. Picciotto, A. Nairn, and P. Lombroso. 2000. The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20:5630-5638.
35. Paulus, W., I. Baur, D. Schuppan, and W. Roggendorf. 1993. Characterization of integrin receptors in normal and neoplastic human brain. Am. J. Pathol. 143:154-163.
36. Pierce, K., M. Luttrell, and R. Lefkowitz. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene. 20:1532-1539.
37. Pluschke, G., M. Vanek, A. Evans, T. Dittmar, P. Schmid, P. Itin, E.J. Filardo, and R.A. Reisfeld. 1996. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Natl. Acad. Sci. USA. 93:9710-9715.
38. Porter, A.C., and R.R. Vaillancourt. 1998. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene. 17:1343-1352.
39. Robin, P., I. Boulven, C. Bole-Feysot, Z. Tanfin, and D. Leiber. 2004. Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Am. J. Physiol. Cell Physiol. 286:C798-C806.
40. Sachinidis, A., R. Locher, W. Vetter, D. Tatje, and J. Hoppe. 1990. Different effects of platelet derived growth factor isoforms on rat vascular smooth muscle cells. J. Biol. Chem. 265:10238-10243.
41. Saxena, M., S. Williams, J. Brockdorff, J. Gilman, and T. Mustelin. 1999. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 274:11693-11700.
42. Schneider, S., F. Bosse, D. D'Urso, H. Muller, M. Sereda, K. Nave, A. Niehaus, T. Kempf, M. Schnolzer, and J. Trotter. 2001. The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells. J. Neurosci. 21:920-933.
43. Stallcup, W.B. 2002. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 31:423-435.
44. Stallcup, W.B., and K. Dahlin-Huppe. 2001. Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization. J. Cell Sci. 114:2315-2325.
45. Stegmuller, J., H. Werner, K.A. Nave, and J. Trotter. 2003. The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling. J. Biol. Chem. 278:3590-3598.
46. Suzuki, S., and J. Goldman. 2003. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J. Neurosci. 23:4240-4250.
47. Tillet, E., F. Ruggiero, A. Nishiyama, and W.B. Stallcup. 1997. The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein. J. Biol. Chem. 272:10769-10776.
48. Tillet, E., B. Gential, R. Garrone, and W.B. Stallcup. 2002. NG2 proteoglycan mediates β1 integrin-independent cell adhesion and spreading on collagen VI. J. Cell. Biochem. 86:726-736.
49. Vinciguerra, M., A. Vivacqua, G. Fasanella, A. Gallo, C. Cuozzo, A. Morano, M. Maggiolini, and A. Musti. 2004. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of the MAPK targeting sequences. J. Biol. Chem. 279:9634-9641.
50. Wen, Y., I.T. Makagiansar, J. Fukushi, F.-T. Liu, M.N. Fukuda, and W.B. Stallcup. 2006. Molecular basis of interaction between NG2 proteoglycan and galectin-3. J. Cell. Biochem. 98:115-127.
51. Wingate, A., D. Campbell, M. Peggie, and J. Arthur. 2006. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem. J. 393:715-724.
52. Xu, B., J. Wilsbacher, T. Collison, and M. Cobb. 1999. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. J. Biol. Chem. 274:34029-34035.
53. Yang, J., M. Price, C. Neudauer, C. Wilson, S. Ferrone, H. Xia, J. Iida, M. Simpson, and J.B. McCarthy. 2004. Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J. Cell Biol. 165:881-891.
54. Yang, S., P. Yates, A. Whitmarsh, R. Davis, and A. Sharrocks. 1998. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol. Cell. Biol. 18:710-720.
55. Yang, Z., R. Suzuki, S. Daniels, C. Brunquell, C. Sala, and A. Nishiyama. 2006. NG2 glial cells provide a favorable substrate for growing axons. J. Neurosci. 26:3829-3839.